1. Home
  2. ALKS vs ORA Comparison

ALKS vs ORA Comparison

Compare ALKS & ORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • ORA
  • Stock Information
  • Founded
  • ALKS 1987
  • ORA 1965
  • Country
  • ALKS Ireland
  • ORA United States
  • Employees
  • ALKS N/A
  • ORA N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • ORA Electric Utilities: Central
  • Sector
  • ALKS Health Care
  • ORA Utilities
  • Exchange
  • ALKS Nasdaq
  • ORA Nasdaq
  • Market Cap
  • ALKS 5.4B
  • ORA 4.4B
  • IPO Year
  • ALKS 1991
  • ORA 2004
  • Fundamental
  • Price
  • ALKS $33.02
  • ORA $70.77
  • Analyst Decision
  • ALKS Buy
  • ORA Buy
  • Analyst Count
  • ALKS 13
  • ORA 8
  • Target Price
  • ALKS $39.50
  • ORA $84.88
  • AVG Volume (30 Days)
  • ALKS 1.7M
  • ORA 512.7K
  • Earning Date
  • ALKS 04-30-2025
  • ORA 05-07-2025
  • Dividend Yield
  • ALKS N/A
  • ORA 0.68%
  • EPS Growth
  • ALKS 3.47
  • ORA N/A
  • EPS
  • ALKS 2.17
  • ORA 2.04
  • Revenue
  • ALKS $1,557,632,000.00
  • ORA $879,654,000.00
  • Revenue This Year
  • ALKS N/A
  • ORA $10.00
  • Revenue Next Year
  • ALKS $4.37
  • ORA $12.13
  • P/E Ratio
  • ALKS $15.10
  • ORA $34.65
  • Revenue Growth
  • ALKS N/A
  • ORA 6.06
  • 52 Week Low
  • ALKS $22.90
  • ORA $59.41
  • 52 Week High
  • ALKS $36.45
  • ORA $84.30
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 42.12
  • ORA 53.99
  • Support Level
  • ALKS $33.22
  • ORA $68.69
  • Resistance Level
  • ALKS $34.45
  • ORA $72.12
  • Average True Range (ATR)
  • ALKS 0.96
  • ORA 1.36
  • MACD
  • ALKS -0.23
  • ORA -0.31
  • Stochastic Oscillator
  • ALKS 28.87
  • ORA 49.06

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About ORA Ormat Technologies Inc.

Ormat Technologies Inc is engaged in the geothermal and recovered energy power business. It is engaged in three business segments: Electricity Segment. where the company develops, builds, owns and operates geothermal, solar PV and recovered energy-based power plants in the United States and geothermal power plants in other countries and sell the electricity generated. Product Segment includes designing, manufacturing and selling equipment for geothermal and recovered energy-based electricity generation and providing services relating to the engineering, procurement and construction of geothermal and recovered energy-based power plants. Energy Storage Segment includes owning and operating grid-connected which provide capacity, energy and ancillary services directly to the electric grid.

Share on Social Networks: